NewTimeSpace News: SH PHARMA (02607.HK) announced that its subsidiary SPH Xinyi has obtained the Drug Registration Certificate for Omeprazole Sodium Bicarbonate for Oral Suspension (I) issued by the National Medical Products Administration, and the drug is approved for production. Each sachet contains 20mg Omeprazole and 1680mg Sodium Bicarbonate. Classified as Class 3 Chemical Drug, it is mainly indicated for short-term treatment of active duodenal ulcer and gastroesophageal reflux disease.
NewTimeSpace News: Ling Yue Services Group Limited (02165.HK) announced on 3 August that it failed to win the public bidding for the land use right in Xichang City, Sichuan Province. The tender deposit of RMB8.33 million has been fully refunded without interest and deductions. The Company will continue to search for investment opportunities.
NewTimeSpace News: Jinhai Medical Technology Limited (02225.HK) announced that Mr. Ma Chengdong has been appointed as the Group’s Chief Marketing Officer, effective 3 August 2026. He will mainly be responsible for product marketing strategies, market access, academic promotion, sales and channel operation of the Group. Graduated from Shanghai Medical University, Mr. Ma boasts over 25 years of experience in marketing and sales management at international medical enterprises including GE Healthcare China and Medtronic China.
NewTimeSpace News: SSY Group (02005.HK) announced that all 16 specifications covering 13 varieties tendered by the Group are proposed to be selected in the bidding of the 12th National Centralized Drug Procurement. The products include Blonanserin Tablets, Betahistine Mesilate Tablets, Vitamin B6 Injection, Acipimox Capsules, Doxazosin Mesilate Sustained-release Tablets, Bisoprolol Amlodipine Tablets and other varieties.
NewTimeSpace News: XPeng Inc. (09868.HK) announced on 4 August that it delivered 38,027 vehicles in July, representing a 4% year-on-year increase. Cumulative global deliveries have surpassed 1.2 million units. The global model L03 will be launched in 65 countries and regions. Five new models will be rolled out in Australia in the second half of the year, and the VLA 2.0 intelligent driving system will be launched globally in 2027. Estimated carbon emission reduction exceeds 3.23 million tonnes from January to July.
NewTimeSpace News: EuroEyes International Eye Clinic Limited (01846.HK) announced that Mr. Rens Laurentius Michaël Schoenmakers has been appointed as an executive director, effective 3 August 2026. Aged 60, Mr. Schoenmakers possesses over 20 years of senior management experience in medical devices, medtech and healthcare sectors. He currently serves as General Manager for Europe of the Group and Chief Executive Officer of EuroEyes Netherlands Holding B.V.
NewTimeSpace News: Fusen Pharmaceutical Company Limited (01652.HK) announced that four of the Group’s products have been proposed to win the bid in the tender of China’s 12th National Centralized Drug Procurement, namely Nicardipine Injection, Azilsartan Potassium Tablets, Potassium Hydrogen Phosphate Compound Injection and Dydrogesterone Tablets.
NewTimeSpace News: Xiabuxiabu announced on August 3 that it expects a net loss of approximately RMB29 million to RMB39 million for the six months ended June 30, 2026. The loss represents a narrowing of roughly 51% to 64%, compared with the loss of RMB81 million in the same period last year.
NewTimeSpace News: CGN POWER (01816.HK) announced that Unit 2 of CGN Huizhou Nuclear Power Co., Limited completed all commissioning works and satisfied the conditions for commercial operation on 3 August 2026. Following the commissioning of Huizhou Unit 2, the number of operating nuclear power units managed by the Company (including joint ventures) increased to 31, and the installed capacity of operating units rose from 34,248 MW to 35,450 MW.
NewTimeSpace News: JS Global Lifestyle announced on August 3 that it expects to record a net profit of no less than US$12 million for the six months ended June 30, 2026, swinging from a net loss of approximately US$53.7 million in the same period last year.
NewTimeSpace News: REGENT PACIFIC GROUP announced on August 3 that it expects to record a profit of approximately US$500,000 to US$1 million for the six months ended June 30, 2026, swinging from a loss of around US$2.22 million in the same period last year.
NewTimeSpace News: Jiu Rong Holdings Limited (02358.HK) released a supplementary announcement disclosing details of remaining mortgaged assets involved in litigation. As at 30 June 2025, the aggregate book value of remaining mortgaged assets stood at approximately RMB134 million, including new energy charging station assets worth about RMB40.22 million and accounts receivable from Banco Nacional de Cuba of roughly RMB93.63 million. After offsetting approximately RMB42 million via assignment of claims, the outstanding loan principal amounted to around RMB188 million, and the book value of mortgaged assets is insufficient to cover the residual principal.
NewTimeSpace News: Sisram Medical Ltd announced on August 3 that it expects a loss attributable to owners of the company of approximately US$900,000 to US$1.4 million for the six months ended June 30, 2026.
NewTimeSpace News: APEX ACE HOLDING announced on August 3 that it expects profit attributable to owners of the company for the six months ended June 30, 2026 to range from HK$130 million to HK$140 million.
NewTimeSpace News: Sino Biopharmaceutical Limited (01177.HK) announced on August 3 that its HER2 bispecific ADC TQB2102 has received its third Breakthrough Therapy Designation (BTD) from CDE, this time for chemotherapy-naïve HER2-low breast cancer. Clinical data demonstrated an ORR of 53%–58%, with efficacy also observed in patients previously treated with ADCs. Approximately 45%–55% of breast cancer patients in China are HER2-low, where existing treatment options remain limited. The Company is advancing multiple Phase III studies.
NewTimeSpace News: August 03, 2026, LEE & MAN PAPER(02314.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 14.84 billion, increased by 21.29% YoY
